Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Berkeley Heights, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Tonix Pharmaceuticals Holding Corp. has filed 1,504 SEC EDGAR filings since 09 Apr 2008

SEC filing history

Showing 26-50 of 1,000 matching filings.

Per page
25
Current page
2
8-K File 001-36019

CURRENT REPORT

Filing date
07 May 2026
Reporting date
07 May 2026
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
06 May 2026
Reporting date
06 May 2026
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
01 May 2026
Reporting date
01 May 2026
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
29 Apr 2026
Reporting date
29 Apr 2026
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
23 Apr 2026
Reporting date
21 Apr 2026
Next action
Verify source filing
4

4 filing

Filing date
01 Apr 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
31 Mar 2026
Reporting date
30 Mar 2026
Next action
Verify source filing
DEF 14A File 001-36019

DEFINITIVE PROXY STATEMENT

Filing date
30 Mar 2026
Reporting date
07 May 2026
Next action
Verify source filing
SCHEDULE 13G/A File 005-86436

SCHEDULE 13G/A filing

Filing date
27 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
26 Mar 2026
Reporting date
26 Mar 2026
Next action
Verify source filing
PRE 14A File 001-36019

PRELIMINARY PROXY STATEMENT

Filing date
20 Mar 2026
Reporting date
07 May 2026
Next action
Verify source filing
4

4 filing

Filing date
18 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
18 Mar 2026
Reporting date
16 Mar 2026
Next action
Verify source filing
ARS File 001-36019

ANNUAL REPORT TO SECURITY HOLDERS

Filing date
13 Mar 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
13 Mar 2026
Reporting date
12 Mar 2026
Next action
Verify source filing
10-K File 001-36019

ANNUAL REPORT

Filing date
12 Mar 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
10 Mar 2026
Reporting date
10 Mar 2026
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
03 Mar 2026
Reporting date
03 Mar 2026
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - SAENGER

Filing date
26 Feb 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

CHANGES IN BENEFICIAL OWNERSHIP

Filing date
26 Feb 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

CHANGES IN BENEFICIAL OWNERSHIP

Filing date
26 Feb 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

CHANGES IN BENEFICIAL OWNERSHIP

Filing date
26 Feb 2026
Reporting date
24 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
17 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36019

CURRENT REPORT

Filing date
03 Feb 2026
Reporting date
03 Feb 2026
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .